China Agrees to Accelerate Drug and Medical Device Approvals

Last week, at the end of an annual high-level meeting of US-China trade officials, it was announced that China agreed to speed up approvals of US drugs and medical devices. China said it would work off its backlog of drugs awaiting approval over the next two to three years, which probably means the CFDA will hire more staff. China also promised it would not ask US pharmas to conduct unnecessary clinical trials. Presumably, these upbeat statements are supported by specific steps, but officials did not release any further details in a post-meeting press conference. More details....

Share this with colleagues: